Investors
Press Releases
Press releases issued by Palatin are accessible below. These press releases contain additional information about our business, clinical trial developments, research and development activities, financial achievements, and strategic partnerships.
Found 316 Results
Palatin Technologies Granted FDA Orphan Drug Designation — PL-8177 for the Treatment of Non-Infectious Uveitis
June 6, 2019
Palatin Technologies, Inc. Reports Second Fiscal Quarter 2019 Results and Provides Corporate Update
February 12, 2019
Palatin Technologies, Inc. to Report Second Quarter Fiscal Year 2019 Results; Teleconference and Webcast to be held on February 12, 2019
February 6, 2019
Page 15 of 32